Real-time enrollment status for this monoclonal gammopathy of undetermined significance clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:50 AM UTC
| NCT Number | NCT05136807 |
| Recruiting Status | Recruiting |
| Condition | Monoclonal Gammopathy of Undetermined Significance |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | April 15, 2026 (Apr 15, 2026) |
As of July 13, 2026: Clinical trial NCT05136807 is currently recruiting participants. This clinical trial study for monoclonal gammopathy of undetermined significance is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05136807 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05136807 was last updated Apr 15, 2026 (April 15, 2026). HelloStudys verifies this status automatically.